
南美洲和中美洲药物输送市场预测至 2028 年 - COVID-19 影响和区域分析 - 按给药途径(注射药物输送、口服药物输送、经粘膜药物输送、局部药物输送、植入式药物输送和眼部药物输送),分销渠道(医院药房、零售药房和在线药房)和最终用户(医院和诊所、家庭护理机构和其他最终用户)
No. of Pages: 228 | Report Code: BMIRE00028763 | Category: Life Sciences
No. of Pages: 228 | Report Code: BMIRE00028763 | Category: Life Sciences
无创给药通常是指跨越粘膜表面或皮肤生物屏障的无痛给药方法。这种药物输送方法可以改善药物的获取、治疗方案的依从性以及更好的药物安全性。由于与注射给药相比具有明显的优势,患者更喜欢无创给药途径。研究发现,通过非侵入性方法给药时,患者的依从性要高得多,因为他们在手术过程中感受到的疼痛减轻了。随着医疗设备和透皮给药技术的改进,无创给药方式现已准备好与传统的口服和注射给药途径竞争。局部给药、透皮主动给药(设备辅助增强渗透)、透皮被动给药、经眼膜、跨粘膜以及吸入药物通过肺泡膜给药是一些流行的非侵入性给药方法。
低排斥率、易于给药、方便且耐用,使 TDDS 成为最具吸引力的药物输送方法。除了医疗机构的药物管理之外,TDDS 还可用于护肤行业的不同程序。由于该方法主要涉及局部给药,因此可以防止药物非特异性递送至非靶向组织。 TDDS 的发展可能有助于控制心血管和中枢神经系统疾病、遗传性疾病、糖尿病、神经肌肉疾病和传染病(包括局部疾病)的患病率,同时推动疫苗接种的进步和患者对长期自我给药的偏好长期治疗。
通过无创方法给药涉及减少给药频率和简化给药方案。此外,这些输送系统可以显着降低临床使用成本,因为患者可以通过这些方法自行给药。在许多情况下,采用无创给药系统的药物的制造成本低于注射剂的生产成本。例如,吸入胰岛素已成为治疗糖尿病的耐受性良好且首选的方式。因此,对无创给药系统不断增长的需求推动了给药系统市场的增长。
南美洲和南美洲中美洲药物输送市场分为巴西、阿根廷和南美洲其他地区。中美洲。由于医疗设备进口的增加、需要先进医疗技术的医疗保健系统的不断发展、慢性病发病率的增加以及老年人口的增加,预计该地区的市场将会增长。
南&中美洲药物输送市场细分
南美洲和南美洲中美洲药物输送市场分为给药途径、分销渠道、最终用户和国家。中美洲药物输送市场分为注射药物输送、口服药物输送、跨粘膜药物输送、局部药物输送、植入式药物输送和眼部药物输送。注射药物输送领域在南美两国占有较大份额。 2023 年中美洲药物输送市场。
根据分销渠道,南美地区中美洲给药市场分为医院药房、零售药房和在线药房。医院药房部门在南部和南部地区占据最大份额。 2023 年中美洲药物输送市场。
根据最终用户,南美洲和南美洲中美洲药物输送市场分为医院和诊所、家庭护理机构和其他最终用户。医院和诊所部门在南部和南部地区占据最大份额。 2023 年中美洲药物输送市场。
按国家/地区划分:南部和非洲中美洲药物输送市场分为巴西、阿根廷和南美洲其他地区。中美洲。巴西在南部和非洲地区占据主导地位。 2023 年中美洲给药市场。
Bausch Health Companies Inc、Baxter International Inc、Becton Dickinson and Co、Boehringer Ingelheim International GmbH、Boston Scientific Corp 、Gerresheimer AG、葛兰素史克公司、强生公司强生公司、诺华公司、诺和诺德公司和辉瑞公司是在南美和北美洲运营的领先公司。中美洲药物输送市场。
Strategic insights for South & Central America Drug Delivery involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2023 | US$ 1,09,189.07 Million |
Market Size by 2028 | US$ 1,42,876.69 Million |
Global CAGR (2023 - 2028) | 5.5% |
Historical Data | 2021-2022 |
Forecast period | 2024-2028 |
Segments Covered |
By 给药途径
|
Regions and Countries Covered | 南美洲和中美洲
|
Market leaders and key company profiles |
The regional scope of South & Central America Drug Delivery refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The South & Central America Drug Delivery Market is valued at US$ 1,09,189.07 Million in 2023, it is projected to reach US$ 1,42,876.69 Million by 2028.
As per our report South & Central America Drug Delivery Market, the market size is valued at US$ 1,09,189.07 Million in 2023, projecting it to reach US$ 1,42,876.69 Million by 2028. This translates to a CAGR of approximately 5.5% during the forecast period.
The South & Central America Drug Delivery Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Drug Delivery Market report:
The South & Central America Drug Delivery Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South & Central America Drug Delivery Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South & Central America Drug Delivery Market value chain can benefit from the information contained in a comprehensive market report.